scispace - formally typeset
C

Caroline Dubertret

Researcher at University of Paris

Publications -  197
Citations -  4091

Caroline Dubertret is an academic researcher from University of Paris. The author has contributed to research in topics: Bipolar disorder & Population. The author has an hindex of 28, co-authored 165 publications receiving 2831 citations. Previous affiliations of Caroline Dubertret include French Institute of Health and Medical Research & Paris Diderot University.

Papers
More filters
Journal ArticleDOI

A genetic schizophrenia-susceptibility region located between the ANKK1 and DRD2 genes.

TL;DR: Intergenic rs2242592 appears to be involved in the genetic vulnerability to schizophrenia, whereas the ANKK1 rs1800497 appears to have a modifying rather than causative effect.
Journal ArticleDOI

Impact of age at onset of cannabis use on cannabis dependence and driving under the influence in the United States

TL;DR: Starting to smoke cannabis younger than 21 years is associated with both cannabis dependence and driving under the influence of cannabis, and an inverse relationship between the age at onset of cannabis use and drivingUnder the influence and risk of cannabis dependence was found.
Journal ArticleDOI

Shorter and longer durations of sleep are associated with an increased twelve-month prevalence of psychiatric and substance use disorders: Findings from a nationally representative survey of US adults (NESARC-III).

TL;DR: U-shaped associations exist between sleep duration and mental disorders, calling for respect to recommendations for adequate sleep duration in routine clinical care as well as to actions for primary prevention in public health settings.
Journal ArticleDOI

Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative

Jan Scott, +76 more
TL;DR: The paper outlines the rationale, design and methodology of the first study being undertaken by the newly established R-LiNK collaboration and describes how the project may help to refine the clinical response phenotype and could translate into the personalization of lithium treatment.